Dr. Maha Mohamed El Sayed Eissa
My Social Links

Dr. Maha Mohamed El Sayed Eissa

Professor
Alexandria University, Egypt


Highest Degree
M.D. in Parasitology from Alexandria University, Alexandria, Egypt

Share this Profile

Biography

Dr. Maha Mohamed El-sayed Eissa is currently working as Professor in Parasitological Department, Faculty of Medicine, Alexandria University, Egypt. She obtained her PhD in Parasitology in 1994 from same university. In past she worked as Demonstrator in Parasitology, Assistant Lecturer, Lecturer, Assistant Professor at Alexandria University, Egypt. She is member of editorial board in number of journals and peer reviewer to international journals. She is member of following scientific societies, Egyptian Society of Parasitology, Research Initiative on Traditional Antimalarial Methods, Alexandria Medical Society, Egyptian Society of Laboratory Medicine, Society of Egyptian Parasitology. Dr. Maha received honors include Alexandria University award for scientific research and award for scientific excellence. She supervised 6 MSc and 3 MD students thesis. She has published 45 research articles in journals.

Area of Interest:

Biomedical Sciences
100%
Parasitology
62%
Tropical Medicine
90%
Parasitic Diseases
75%
Pathology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
43
Abstracts
0

Selected Publications

  1. Eissa, M.M., C.A. Ismail, M.Z. El-Azzouni, A.A. Ghazy and M.A. Hadi, 2019. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer. Invest. New Drugs, 37: 47-56.
    CrossRef  |  Direct Link  |  
  2. Eissa, M.M., C.A. Ismail, M.Z. El-Azzouni, A.A. Ghazy and M.A. Hadi, 2018. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer. Invest. N. Drugs, 10.1007/s10637-018-0609-6.
    CrossRef  |  Direct Link  |  
  3. Amara1, R.O., A.A. Ramadan, R.M. El-Moslemany, M.M. Eissa, M.Z. El-Azzouni and L.K. El-Khordagui, 2018. Praziquantel lipid nanocapsules: An oral nanotherapeutic with potential Schistosoma mansoni Tegumental Targeting. Int. J. Nanomed. (In Press). .
  4. Amara, R.O., A.A. Ramadan, R.M. El-Moslemany, M.M. Eissa, M.Z. El-Azzouni and L.K. El-Khordagui, 2018. Praziquantel-lipid nanocapsules: An oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting. Int. J. Nanomed., 13: 4493-4505.
    CrossRef  |  Direct Link  |  
  5. El-Faham, M H., M.M. Eissa, J.E. Igetei, E.I. Amer, S. Liddell, M.Z. El-Azzouni and M.J. Doenhoff, 2017. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens. Plos Neglect. Trop. Dis., Vol. 11. 10.1371/journal.pntd.0005853.
    CrossRef  |  Direct Link  |  
  6. Eissa, M.M., S.F. Mossallam, E.I. Amer, L.K. Younis and H.A. Rashed, 2017. Repositioning of chlorambucil as a potential anti-schistosomal agent. Acta Trop., 166: 58-66.
    CrossRef  |  Direct Link  |  
  7. Elsakkar, M.G., M.M. Eissa, W.A. Hewedy, R.M. Nassra and S.F. Elatrebi, 2016. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice. Life Sci., 162: 95-101.
    CrossRef  |  Direct Link  |  
  8. El-Moslemany, R.M., M.M. Eissa, A.A. Ramadan, L.K. El-Khordagui and M.Z. El-Azzouni, 2016. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent Schistosomiasis mansoni. Acta Trop., 159: 142-148.
    CrossRef  |  Direct Link  |  
  9. Eissa, M.M., D.K. Mostafa, A.A. Ghazy, L.M. Boulos and L.K. Younis, 2016. Anti-arthritic activity of Schistosoma mansoni and Trichinella spiralis derived-antigens in adjuvant arthritis in rats: Role of FOXP3+ treg cells. Plos One, Vol. 11. 10.1371/journal.pone.0165916.
    CrossRef  |  Direct Link  |  
  10. Eissa, M.M., R.M. El-Moslemany, A.A. Ramadan, E.I. Amer, M.Z. El-Azzouni and L.K. El-Khordagui, 2015. Miltefosine lipid nanocapsules for single dose oral treatment of Schistosomiasis mansoni: A preclinical study. Plos One, Vol. 10. 10.1371/journal.pone.0141788.
    CrossRef  |  Direct Link  |  
  11. Eissa, M.M., A. Barakat, E.I. Amer and L.K. Younis, 2015. Could miltefosine be the new therapy for toxoplasmosis? Exp. Parasitol., 157: 12-22.
  12. El Temsahy, M.M., E.D. El Kerdany, M.M. Eissa, T.I. Shalaby, I.M. Talaat and N.M. Mogahed, 2014. The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice. J. Paras. Dis., 10.1007/s12639-014-0546-z.
    CrossRef  |  Direct Link  |  
  13. Amer, E.I., M.M. Eissa and S.F. Mossallam, 2014. Oral azithromycin versus its combination with miltefosine for the treatment of experimental old world cutaneous leishmaniasis. J. Paras. Dis., 10.1007/s12639-014-0529-0.
    CrossRef  |  
  14. Saudi, M.N.S., M.M.A. El-Semary, R.Y. Elbayaa, M.I. Jaeda, M.M. Eissa, E.I. Amer and N.M. Baddour, 2012. Synthesis and Biological evaluaion of a novel classes of antileishmanial agents. Med. Chem. Res., 21: 257-267.
    CrossRef  |  Direct Link  |  
  15. Eissa, M.M., M.Z. El-Azzouni, R. Mady, F.M. Fathy and N.M. Baddour, 2012. Initial characterization of an autoclaved Toxoplasma vaccine against experimental toxoplasmosis. Exp. Parasitol., 131: 310-316.
    Direct Link  |  
  16. Eissa, M.M., E.I. Amer, S.F. Mossallam, M.M. Gomaa and N.M. Baddour, 2012. Miltefosine for Old World cutaneous leishmaniasis: An experimental study on Leishmania major infected mice. Alex. J. Med., 48: 261-271.
    Direct Link  |  
  17. Eissa, M.M. and E.I. Amer, 2012. Giardia lamblia, a new target for miltefosine. Int. J. Parasitol., 42: 443-452.
    Direct Link  |  
  18. Eissa, M.M., S. El Bardicy and M. Tadros, 2011. Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy. Parasites Vectors, Vol. 4. 10.1186/1756-3305-4-73.
    CrossRef  |  Direct Link  |  
  19. Eissa, M.M., M.Z. El-Azzouni, E.I. Amer and N.M. Baddour, 2011. Miltefosine, a promising novel agent for schistosomiasis mansoni. Int. J. Parasitol., 41: 235-242.
    CrossRef  |  
  20. Eissa, M.M., E.I. Amer and S.M. El Sawy, 2011. Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis. Exp. Parasitol., 128: 382-390.
    CrossRef  |  
  21. Naga, E., I.F. Abou, , M.M. Eissa, , S.F. Mossallam and S.I.A. El-Halim, 2010. Inheritance of Schistosoma mansoni infection incompatibility in Biomphalaria alexandrina snails. Mem. Inst. Oswaldo Cruz, 105: 149-154.
    CrossRef  |  Direct Link  |  
  22. Saudi, M.N., A.M. Youssef, M.H. Badr, R.Y. Elbayaa, M.Z. El-Azzouni, S.F. Mossallam and M.M. Eissa, 2009. Synthesis of substituted pyrimidinedione derivatives as potential schistosomicidal agents. Lett. Drug Des. Discovery, 6: 268-277.
    CrossRef  |  Direct Link  |  
  23. Saudi, M.N.S., M.R. Gaafar, M.Z. El-Azzouni, M.A. Ibrahim and M.M. Eissa, 2008. Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis. Med. Chem. Res., 17: 541-563.
    CrossRef  |  
  24. Michel, M.Y., F.M. Fathy, E.H. Hegazy, E.D. Hussein, M.M. Eissa and D.E. Said, 2006. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis. J. Egyp. Soc. Parasitol., 36: 159-176.
    Direct Link  |  
  25. Gaffer, M.R., M.M. Eissa, Y. El Ashram, E. Deab, N.M. Baddour and M.Z. El-Azzouni, 2006. Experimental trichinosis: Parasitological,histopathological and biochemical studies. Egypt, J. Egyp. Soc. Parasitol., 36: 455-466.
  26. Maha, M.E., M.Z. El-Azzouni and M. B. laila, 2003. Vaccination trial against experimental Trichinosis using autoclaved Trichinella spiralis larva vaccine (ATSLV). J. Egypt. Soc. Parasitol., 33: 219-228.
    PubMed  |  
  27. Eissa, M.M., S.T. El-Mansoury and S.R. Allam, 2003. CO.A: A rapid test for the diagnosis of experimental trichinosis. J. Egypt. Soc. Parasitol., 33: 637-645.
    PubMed  |  
  28. Eissa, M.M., S.R. Allam, M.Z. El-Azzouni, H.R. Maged and I.S. Dessouky, 2003. Further studies on Autoclaved cercarial vaccine against scShistosomiasis safety, longivity and stability. J. Egypt. Soc. Parasitol., 33: 541-560.
  29. Eissa, M.M., S.R. Allam, , M.Z. El-Azzouni, H.R. Maged and I.S. Dessouky, 2003. Further studies on autoclaved cercarial vaccine against schistosomiasis: safety, longevity and stability. J. Egypt. Soc. Parasitol., 33: 541-560.
    PubMed  |  
  30. Eissa, M.M., A.S. Soliman and S.O. Nassar, 2003. Ultrastructural and Immunological features of experimental cutaneous leishmaniasis after treatment with intralesional hypertonic sodium chloride and CO2 laser rays. J. Egypt. Soc. Parasitol., 33: 329-352.
    Direct Link  |  
  31. Allam, S.R., H.A.H. Sadaka, M.M. Eissa and H.A. Rezk, 2002. In vitro effects of ivermectin on adult and developmental stages of two species of blood feeding arthropods. Acarid Phylogeny Evol., 10.1007/978-94-017-0611-7_46.
    CrossRef  |  Direct Link  |  
  32. El-Korrany, S., H.I.H. Ismail, F.A. Sallam, S.O. Nassar and M.M. Eissa, 2001. The role of Fas-FasL system in induction of apoptosis in cutaneous leishmaniasis. A combined human and experimental study. J. Egypt. Soc. Parasitol., 31: 245-256.
  33. Sonia R.A., A.H.S. Hayam and M.E. Maha, 1999. A Novel macrolide in mixed intestinal protozoal infection on immunosuppressed mice. J. Med. Res. Inst., 20: 149-159.
    PubMed  |  
  34. El Azzouni, M.Z., M.M. Eissa, H.A. Sadaka and N.M. Baddour, 1998. Studies on experimental mixed infection of Schistosoma haematobium and Schistosoma mansoni. J. Egypt. Soc. Parasitol., 28: 229-245.
    PubMed  |  
  35. Eissa, M.M., S.R. Allam, M.Z. El Azzouni and N.M. Baddour, 1998. Autoclaved cercarial vaccine: a new hope against schistosomiasis parasitologic, histopathologic and immunologic studies. J. Egypt. Soc. Parasitol., 28: 461-479.
    PubMed  |  
  36. Youssef, M.Y., M.M. Eissa and S.T. El Mansoury, 1997. Evidence of sexual reproduction in the protozoan parasite leishmania of the old world. J. Egypt. Soc. Parasitol., 27: 651-657.
    PubMed  |  
  37. Youssef, M.Y., M.M. Eissa and S.T. El Mansoury, 1997. Confirmation of clinical differentiation of three Leishmania strains by computerized image analyser system. J. Egypt. Soc. Parasitol., 27: 553-561.
    PubMed  |  
  38. Eissa, M.M., L.K. Younis and E.A. Badawy, 1997. Ultrastructure study of experimental cutaneous leishmaniasis before and after dapsone intake. J. Egypt. Soc. Parasitol., 27: 539-552.
    PubMed  |  
  39. Youssef, M.Y., M.M. Essa, H.A. Sadaka, M.M. Eissa and A.M. Rizk, 1996. Effect of ivermectin on combined intestinal protozoal infection (giardiasis and cryptosporidiosis). J. Egypt. Soc. Parasitol., 26: 543-553.
    PubMed  |  
  40. Youssef, M.Y., M.M. Eissa, I.F. El-Naga and S.H. El-Gowhary, 1996. Dissemination of leishmania to organs of mice experimentally infected with Leishmania tropica. J. Egypt. Soc. Parasitol., 26: 719-731.
    PubMed  |  
  41. Youssef, M.Y., H.A. Sadaka, M.M. Eissa and A.F. El-Ariny, 1995. Topical application of ivermectin for human ectoparasites. Am. J. Trop. Med. Hyg., 53: 652-653.
    PubMed  |  
  42. Youssef, M.Y.M., M.M, Eissa and S.H. El Gowhary, 1994. Ivermectin in human leishmaniasis. J. Trop. Med. Hepatol. Infec. Dis., 3: 69-76.
  43. El-Nassery, S.M.F., I.F.A. El-Naga, M.M. Eissa, E.A. Rashwan and H.M. Sharshira, 1994. Effect of graded infections with toxocara canis eggs on local pulmonary and systemic immune responses. Bull. Alex. Fac. Med., 30: 1157-1162.